An immunoassay for type I collagen α1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosis
- 31 January 2003
- Vol. 32 (1) , 20-26
- https://doi.org/10.1016/s8756-3282(02)00922-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Markers of Bone Turnover for Monitoring Treatment of Osteoporosis with Antiresorptive DrugsOsteoporosis International, 2000
- The Use of Biochemical Markers of Bone Turnover in OsteoporosisOsteoporosis International, 2000
- A dose-ranging trial of a matrix transdermal 17β-estradiol for the prevention of bone loss in early postmenopausal womenBone, 1999
- Matrix Delivery Transdermal 17β-Estradiol for the Prevention of Bone Loss in Postmenopausal WomenOsteoporosis International, 1999
- The Collagenolytic Activity of Cathepsin K Is Unique among Mammalian ProteinasesJournal of Biological Chemistry, 1998
- Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: The OFELY studyJournal of Bone and Mineral Research, 1996
- Accurate assessment of precision errors: How to measure the reproducibility of bone densitometry techniquesOsteoporosis International, 1995
- Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretionJournal of Bone and Mineral Research, 1995
- Immunoassay of pyridinoline crosslink excretion in normal adults and in paget's diseaseJournal of Bone and Mineral Research, 1993
- Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatographyAnalytical Biochemistry, 1984